Market News & Trends
Oncologie Announces Clinical Trial Collaboration With Merck
Oncologie, Inc. recently announced it has entered into a clinical collaboration agreement with Merck (known as MSD outside the US and Canada) to evaluate the…
Mustang Bio Announces $9.28-Million Grant to Fund Phase 1 Trial
Mustang Bio, Inc. recently announced that City of Hope has received a $9.28-million grant from the California Institute for Regenerative Medicine (CIRM) to fund an…
Preliminary Data Confirm Saphyr’s Potential to Replace Traditional Cytogenetics Methods
Bionano Genomics, Inc. recently announced a summary of results from two key studies presented this week at the 2019 Cancer Genomics Consortium Annual Meeting in…
Prostate Cancer Treatment Moving Toward Personalized Approach With 6 New Drugs in the Pipeline
Although options for prostate cancer have historically been limited, the late-stage prostate cancer pipeline holds promise for the future of this second most common cancer…
Cytovation & SMS-oncology Sign Agreement on Conduct of Phase 1/2 Trial
Cytovation AS and Specialized Medical Services-oncology BV recently announce that SMS-oncology has been selected as the CRO to conduct the Phase 1/2 clinical trial with…
AC Immune Announces Research Collaboration With University of Pennsylvania
AC Immune SA recently announced a research partnership with leading scientists in the Perelman School of Medicine at the University of Pennsylvania (Penn) focused on studying the pathological mechanisms of…..
CureVac Enters Exclusive Collaborative Research Agreement
CureVac AG recently announced it has entered into a Collaborative Research Agreement with Yale University for discovery research into mRNA-based……
Saama & Comprehend to Form Preeminent Clinical Analytics Platform Company
Saama Technologies, Inc. recently announced it has signed a definitive agreement to acquire Comprehend Systems, Inc. to create an exciting, enhanced suite of………..
Co-Processed Excipient for Direct Compression Designed for Orally Disintegrating Tablets
Developing ODTs is a worldwide trend. In recent years, new excipients and excipient blends have enabled manufacturers to produce ODTs using conventional equipment, ie, blenders and tablet presses. One such product is GRANFILLER-D………
INmune Bio Reports Positive Preliminary Data from INB03 Phase 1 Clinical Trial
INmune Bio, Inc. recently reported positive preliminary data during a presentation at Cambridge Healthtech Institute’s 7th Annual Immuno-Oncology Summit in Boston. INB03 is being developed…
Aquinox Pharmaceuticals & Neoleukin Therapeutics Announce Merger Agreement
Aquinox Pharmaceuticals, Inc. and Neoleukin Therapeutics, Inc. recently announced the two companies entered into a definitive merger agreement under which Aquinox agreed to the acquisition…
Celsion Announces Data Lock for First Interim Analysis in OPTIMA Phase 3 Study
Celsion Corporation recently announces the prescribed number of events has been reached for the first prespecified interim analysis of the OPTIMA Phase 3 Study with…
Eureka Therapeutics Announces Initiation of Phase 1/2 Clinical Trial
Eureka Therapeutics, Inc. recently announced initiation of Phase 1/2 clinical trial of ET140202 ARTEMIS T-cell therapy in liver cancer at City of Hope, a world-renowned…
Cytel Launches East On Demand Bringing Adaptive Clinical Trial Design Capabilities to Wider Biopharma Audience
Cytel Inc. recently announced that it will launch East On Demand at the annual Joint Statistical Meetings (JSM) 2019 (July 27-August 1, Denver, CO). Offered…
Oncternal Therapeutics Announces Opening of Randomized Phase 2 Study
Oncternal Therapeutics, Inc. recently announced it has opened for enrollment its randomized Phase 2 study of cirmtuzumab, a ROR1-targeted monoclonal antibody, combined with ibrutinib in…
Creating Your Secondary Packaging Strategy - Begin With the End in Mind
Whether it is meeting the needs of a rapidly aging market, blocking drug counterfeiters, or differentiating your pharmaceutical product in the market, a secondary packaging program is an important factor in………
MilliporeSigma Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab
MilliporeSigma has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and…..
Huge Untapped Potential for Rheumatoid Arthritis Treatment by Targeting OX40
A new study led by experts from the University of Tsukuba first published in Annals of the Rheumatic Diseases in July found that OX40-expressing follicular helper T cells contributed to inflammation by regulating……
Spring Bank Announces Collaborative Research Agreement with University of Texas Southwestern Medical School
Spring Bank Pharmaceuticals, Inc. recently announced that it has entered into a research agreement with the University of Texas Southwestern Medical School to evaluate….
Colorcon & TruTag Technologies Enter Development Agreement
Colorcon and TruTag Technologies, Inc. recently announced execution of a development agreement to enable on-dose verification technology for tablets by combining TruTag’s….
